Silke Laßmann

4.1k total citations
87 papers, 2.7k citations indexed

About

Silke Laßmann is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Silke Laßmann has authored 87 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Molecular Biology, 42 papers in Oncology and 17 papers in Cell Biology. Recurrent topics in Silke Laßmann's work include Microtubule and mitosis dynamics (14 papers), Genetic factors in colorectal cancer (10 papers) and Cancer-related Molecular Pathways (9 papers). Silke Laßmann is often cited by papers focused on Microtubule and mitosis dynamics (14 papers), Genetic factors in colorectal cancer (10 papers) and Cancer-related Molecular Pathways (9 papers). Silke Laßmann collaborates with scholars based in Germany, United States and Austria. Silke Laßmann's co-authors include Martin Werner, Ulrich T. Hopt, Axel Walch, Uta Jütting, Frank Makowiec, Heinz Höfler, Iain L. Campbell, Annette Hasenburg, Axel Pagenstecher and G. Gitsch and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and The Journal of Experimental Medicine.

In The Last Decade

Silke Laßmann

86 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Silke Laßmann Germany 31 1.2k 1.1k 453 431 387 87 2.7k
Feng Gu China 34 1.6k 1.4× 1.0k 0.9× 494 1.1× 989 2.3× 328 0.8× 146 3.2k
Johan Lennartsson Sweden 31 1.8k 1.5× 715 0.6× 880 1.9× 321 0.7× 249 0.6× 76 3.5k
Keishi Makino Japan 27 1.5k 1.3× 1.0k 0.9× 292 0.6× 583 1.4× 331 0.9× 95 4.2k
Andrew M. Donson United States 35 1.7k 1.4× 632 0.6× 462 1.0× 536 1.2× 290 0.7× 112 3.0k
Frits Thorsen Norway 36 1.6k 1.4× 955 0.9× 358 0.8× 972 2.3× 155 0.4× 84 4.0k
Meena Gujrati United States 35 1.5k 1.2× 652 0.6× 220 0.5× 1.0k 2.4× 323 0.8× 87 3.0k
Naoki Shinojima Japan 26 1.3k 1.0× 682 0.6× 221 0.5× 602 1.4× 262 0.7× 80 3.0k
Joon H. Uhm United States 37 1.7k 1.4× 907 0.8× 380 0.8× 1.1k 2.7× 456 1.2× 127 4.4k
Neill A. Giese United States 26 2.2k 1.8× 650 0.6× 741 1.6× 484 1.1× 920 2.4× 43 4.5k
Motoo Nagane Japan 28 2.5k 2.0× 1.3k 1.2× 448 1.0× 959 2.2× 444 1.1× 113 4.3k

Countries citing papers authored by Silke Laßmann

Since Specialization
Citations

This map shows the geographic impact of Silke Laßmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silke Laßmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silke Laßmann more than expected).

Fields of papers citing papers by Silke Laßmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Silke Laßmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silke Laßmann. The network helps show where Silke Laßmann may publish in the future.

Co-authorship network of co-authors of Silke Laßmann

This figure shows the co-authorship network connecting the top 25 collaborators of Silke Laßmann. A scholar is included among the top collaborators of Silke Laßmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Silke Laßmann. Silke Laßmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cárdenas, Rubí M.-H. Velasco, Simon M. Brandl, Alexandra Emilia Schlaak, et al.. (2023). Harnessing CD3 diversity to optimize CAR T cells. Nature Immunology. 24(12). 2135–2149. 42 indexed citations
2.
Laßmann, Silke & Michael Hummel. (2021). Molekulare Tumorboards – Einblicke und Ausblicke. Der Pathologe. 42(4). 357–362. 1 indexed citations
3.
Lang, Alexander E., Lars Kaiser, Silke Laßmann, et al.. (2017). Targeted delivery of an ADP-ribosylating bacterial toxin into cancer cells. Scientific Reports. 7(1). 41252–41252. 20 indexed citations
4.
5.
Ahrens, Theresa D., Sylvia Timme, Jens Hoeppner, et al.. (2015). Response of esophageal cancer cells to epigenetic inhibitors is mediated via altered thioredoxin activity. Laboratory Investigation. 96(3). 307–316. 13 indexed citations
6.
Hergeth, Sonja, et al.. (2015). Aurora B expression and histone variant H1.4S27 phosphorylation are no longer coordinated during metaphase in aneuploid colorectal carcinomas. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 466(5). 503–515. 2 indexed citations
7.
Herr, Ricarda, M. Köhler, Hana Andrlová, et al.. (2014). B-Raf Inhibitors Induce Epithelial Differentiation in BRAF -Mutant Colorectal Cancer Cells. Cancer Research. 75(1). 216–229. 42 indexed citations
8.
Rönsch, Kerstin, Sylvia Timme, Hana Andrlová, et al.. (2014). Silencing of the EPHB3 tumor-suppressor gene in human colorectal cancer through decommissioning of a transcriptional enhancer. Proceedings of the National Academy of Sciences. 111(13). 4886–4891. 30 indexed citations
9.
Ahrens, Theresa D., Martin Werner, & Silke Laßmann. (2014). Epigenetics in esophageal cancers. Cell and Tissue Research. 356(3). 643–655. 28 indexed citations
10.
Halbach, Sebastian, Konrad Aumann, Sven Schwemmers, et al.. (2012). Gab2 signaling in chronic myeloid leukemia cells confers resistance to multiple Bcr-Abl inhibitors. Leukemia. 27(1). 118–129. 42 indexed citations
11.
12.
Manthey, Carolin, Demissew Shenegelegn Mern, Anne J. Zielinski, et al.. (2010). Elevated endogenous expression of the dominant negative basic helix-loop-helix protein ID1 correlates with significant centrosome abnormalities in human tumor cells. BMC Cell Biology. 11(1). 2–2. 15 indexed citations
13.
Harder, Jan, Henning Usadel, Silke Laßmann, et al.. (2009). CpG-island methylation of the ER promoter in colorectal cancer: analysis of micrometastases in lymph nodes from UICC stage I and II patients. British Journal of Cancer. 100(2). 360–365. 21 indexed citations
14.
Riener, Marc‐Oliver, Alexander Herr, Peter J. Wild, et al.. (2008). Microarray comparative genomic hybridization analysis of tubular breast carcinoma shows recurrent loss of the CDH13 locus on 16q. Human Pathology. 39(11). 1621–1629. 26 indexed citations
15.
Wiese, Anja, Johannes Auer, Silke Laßmann, et al.. (2007). Identification of gene signatures for invasive colorectal tumor cells. Cancer Detection and Prevention. 31(4). 282–295. 53 indexed citations
16.
Laßmann, Silke, Roland Weís, Frank Makowiec, et al.. (2006). Array CGH identifies distinct DNA copy number profiles of oncogenes and tumor suppressor genes in chromosomal- and microsatellite-unstable sporadic colorectal carcinomas. Journal of Molecular Medicine. 85(3). 293–304. 124 indexed citations
17.
Bredel, Claudia, Silke Laßmann, Ian F. Pollack, et al.. (2005). DNA topoisomerase IIα and Her-2/neu gene dosages in pediatric malignant gliomas. International Journal of Oncology. 26(5). 1187–92. 1 indexed citations
18.
Rosenberg, Robert, et al.. (2003). Telomere Length and hTERT Expression in Patients with Colorectal Carcinoma. Recent results in cancer research. 162. 177–181. 14 indexed citations
19.
Laßmann, Silke, Carrie Kincaid, Valérie C. Asensio, & Iain L. Campbell. (2001). Induction of Type 1 Immune Pathology in the Brain Following Immunization Without Central Nervous System Autoantigen in Transgenic Mice With Astrocyte-Targeted Expression of IL-12. The Journal of Immunology. 167(9). 5485–5493. 15 indexed citations
20.
Pagenstecher, Axel, Silke Laßmann, Monica J. Carson, et al.. (2000). Astrocyte-Targeted Expression of IL-12 Induces Active Cellular Immune Responses in the Central Nervous System and Modulates Experimental Allergic Encephalomyelitis. The Journal of Immunology. 164(9). 4481–4492. 86 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Feng Gu Breakdown of academic impact, for papers by Johan Lennartsson Breakdown of academic impact, for papers by Keishi Makino Breakdown of academic impact, for papers by Andrew M. Donson Breakdown of academic impact, for papers by Frits Thorsen Breakdown of academic impact, for papers by Meena Gujrati Breakdown of academic impact, for papers by Naoki Shinojima Breakdown of academic impact, for papers by Joon H. Uhm Breakdown of academic impact, for papers by Neill A. Giese Breakdown of academic impact, for papers by Motoo Nagane
Rankless by CCL
2026